TIGIT and cancer: These results identified TIGIT as a crucial and hitherto overlooked checkpoint in NK cells, indicating that targeting TIGIT alone or in conjunction with other checkpoint receptors may offer a feasible treatment strategy for cancer (Zhang et al., 2018).